<DOC>
	<DOC>NCT02194608</DOC>
	<brief_summary>The primary goal is to evaluate whether a home telehealth system that enables the participant to monitor their body weight, blood glucose values and blood pressure values, associated with remote educational support and feedback to the general practitioner, can improve metabolic control and overall cardiovascular risk in individuals with type 2 diabetes mellitus (T2DM), as compared to usual practice.</brief_summary>
	<brief_title>Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>has type 2 diabetes treated with oral agents in monotherapy or combined therapy Â± basal insulin previously educated to selfmonitoring blood glucose (SMBG) use has type 2 diabetes nonpharmacologically treated has type 2 diabetes treated with multiple daily injections of insulin is unable to use the telemedicine system pregnancy has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>